An observational study published in the journal JACC Heart Failure raises alarming questions about the type 2 diabetes drug Januvia (sitagliptin) and heart failure. The study involved an analysis of insurance claims from a database of more than 7,600 patients with diabetes and heart failure. Researchers found that people who took Januvia were just as likely as people who did not use Januvia to die or be hospitalized for any reason. However, patients using the drug were more likely to be hospitalized for heart failure. Researchers say the results could impact whether Januvia is prescribed as an add-on therapy for ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.